Difficulty: Medium
Average Score: 95%
Practice
This drug is associated with Torsades de pointes:
Correct answer
B
Rationale
In this question, the correct answer is B) Sotalol. Sotalol is a non-selective beta-blocker with Class III antiarrhythmic properties. It prolongs the action potential duration and QT interval, which can lead to the development of Torsades de pointes, a specific type of ventricular tachycardia associated with QT prolongation.
Option A) Flecainide is a Class Ic antiarrhythmic drug that can worsen existing arrhythmias but is not specifically linked to Torsades de pointes.
Option C) Lidocaine is a Class Ib antiarrhythmic drug primarily used for ventricular arrhythmias associated with acute myocardial infarction. It is not known to cause Torsades de pointes.
Option D) Verapamil is a calcium channel blocker that is not associated with Torsades de pointes. It acts primarily on the AV node and is used for rate control in atrial fibrillation.
Educationally, understanding the proarrhythmic potential of different antiarrhythmic drugs is crucial for nurses caring for patients on these medications. Recognizing the risk factors and monitoring for signs of Torsades de pointes can prevent serious complications. Remembering that Sotalol, due to its QT-prolonging effects, can trigger this specific arrhythmia is essential for safe medication administration and patient care.
Option A) Flecainide is a Class Ic antiarrhythmic drug that can worsen existing arrhythmias but is not specifically linked to Torsades de pointes.
Option C) Lidocaine is a Class Ib antiarrhythmic drug primarily used for ventricular arrhythmias associated with acute myocardial infarction. It is not known to cause Torsades de pointes.
Option D) Verapamil is a calcium channel blocker that is not associated with Torsades de pointes. It acts primarily on the AV node and is used for rate control in atrial fibrillation.
Educationally, understanding the proarrhythmic potential of different antiarrhythmic drugs is crucial for nurses caring for patients on these medications. Recognizing the risk factors and monitoring for signs of Torsades de pointes can prevent serious complications. Remembering that Sotalol, due to its QT-prolonging effects, can trigger this specific arrhythmia is essential for safe medication administration and patient care.